Referral pathway study for blood and protein in urine
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at ways to help people with blood and protein in their urine get referred to a kidney specialist. If you have these signs and are not already seeing a kidney doctor, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are a patient at Geisinger and have seen a Geisinger primary care provider in the last 2 years.
- You have had a urine test in the past 12 months showing blood (1+ or more) and protein (2+ or 3+ or a ratio of 300 or more).
- You have not seen a kidney specialist (nephrologist) in the past year.
- You do not have kidney failure, have not had a kidney transplant, and are not receiving palliative care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at why people are admitted to the hospital as an emergency because of blood in their urine (hematuria). If you are being cared for by the urology team and stay for at least a day, you might be able to join.
This study looks at blood samples from people with kidney problems to learn more about the condition and find better ways to treat it.
This study collects health information and biological samples to better understand kidney disease and support future kidney research. It may help your care indirectly by improving how kidney conditions are recognized and studied.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
This trial looks at how immune cells and gut (microbiota) changes relate to nephrotic syndrome flare-ups, and how a treatment approach may help during active attacks. You may be able to take part if you’re currently having a flare with high protein in your urine and meet key safety rules.
This trial is for people with a primary (main) kidney disease who can regularly see a kidney doctor. It sets up and includes patients for possible interventional (active) research studies, which may help improve kidney care for future patients.
Hear when a new Glomerulonephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.